INNVHealthcare · Medical Care FacilitiesINNV Stock Forecast: InnovAge Holding Corp. Price Predictions for 2026-2027
The 3 Wall Street analysts covering InnovAge Holding Corp. hold a median 12-month price target of $7 — -36.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 96 of 100 as at 22 Aug 2026 — among the strongest tenth. The factors read stronger than the Street's target implies. That gap is the story on this page.
INNV stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores InnovAge Holding Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (95): Reported profit is backed by cash, and the company is not expanding recklessly.
Value (46): The shares cost a lot relative to the profits and assets behind them.
Size (40): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
INNV stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on INNV, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits −36.1% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 21 Aug 2026 | Keybanc | Upgrade | Overweight | $13 |
| 23 Feb 2026 | JP Morgan | Maintains | Underweight | $5.00 → $7.00 |
| 18 Sept 2025 | JP Morgan | Assumes | Underweight | $5.00 |
| 17 Dec 2024 | JP Morgan | Downgrade | Underweight | — |
| 11 Oct 2024 | Keybanc | Initiates | Sector Weight | — |
| 13 Mar 2024 | JP Morgan | Maintains | Neutral | — |
| 8 Feb 2024 | Goldman Sachs | Maintains | Neutral | — |
| 15 Feb 2023 | Goldman Sachs | Maintains | Neutral | — |
| 8 Feb 2023 | JP Morgan | Maintains | Neutral | — |
| 23 Nov 2022 | Goldman Sachs | Maintains | Neutral | — |
| 16 Nov 2022 | Citigroup | Maintains | Neutral | — |
| 15 Sept 2022 | Barclays | Maintains | Equal-Weight | — |
| 16 May 2022 | Baird | Downgrade | Neutral | — |
| 11 May 2022 | Piper Sandler | Maintains | Underweight | — |
| 20 Apr 2022 | Piper Sandler | Downgrade | Underweight | — |
| 28 Dec 2021 | Goldman Sachs | Downgrade | Neutral | — |
| 27 Dec 2021 | Barclays | Downgrade | Equal-Weight | — |
| 17 Dec 2021 | JP Morgan | Initiates | Neutral | — |
| 29 Sept 2021 | Citigroup | Downgrade | Neutral | — |
| 22 Sept 2021 | William Blair | Downgrade | Market Perform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. INNV appears on the weeks it earns a place.
INNV analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
InnovAge Holding Corp. (INNV) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 162.4×
- Price / sales
- 1.6×
- Price / book
- 6.5×
- EV / EBITDA
- 62.6×
Cheaper than 4% of US stocks
Cheaper than 59% of US stocks
Cheaper than 17% of US stocks
Cheaper than 4% of US stocks
- Revenue growth (YoY)
- 15.5%
- Earnings growth (YoY)
- 15.5%
- Gross margin
- 24.2%
- Operating margin
- −11.5%
- Net margin
- −1.2%
Higher than 63% of US stocks
Higher than 54% of US stocks
Higher than 27% of US stocks
Higher than 24% of US stocks
Higher than 28% of US stocks
- Return on equity
- −5.9%
- Return on assets
- 0.7%
- Dividend yield
- —
Higher than 38% of US stocks
Higher than 47% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
INNV vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own InnovAge Holding Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about INNV stock
What is the INNV stock price forecast for 2026-2027?
The 3 Wall Street analysts covering InnovAge Holding Corp. have a median 12-month price target of $7, with estimates ranging from $7 to $7. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is INNV stock a buy right now?
Of the 3 analysts covering InnovAge Holding Corp., 0 rate it a Buy, 2 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks InnovAge Holding Corp. 96 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank INNV?
As at 22 Aug 2026, InnovAge Holding Corp. ranks 96 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (95 of 100).
Will INNV stock go up?
No one can know that. What the data says: the median 12-month target from 3 analysts implies -36.1% from the last close, and Ticker Nerd's factor model ranks InnovAge Holding Corp. 96 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the INNV stock forecast for 2030?
No analyst covering InnovAge Holding Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for INNV are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $7 to $7 over the next 12 months.
How has INNV stock performed over the past year?
InnovAge Holding Corp. returned +217.7% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does InnovAge Holding Corp. do?
InnovAge Holding Corp. is a premier healthcare services company, primarily focusing on providing comprehensive healthcare solutions to seniors.
About InnovAge Holding Corp.
InnovAge Holding Corp. is a premier healthcare services company, primarily focusing on providing comprehensive healthcare solutions to seniors. The company's key initiative is the Program of All-Inclusive Care for the Elderly (PACE), which seeks to enhance the quality of life for older adults by delivering holistic, integrated medical and social services. InnovAge's facilities, which include day centers, enable seniors to receive extensive healthcare and social interaction while remaining in their communities. This model significantly impacts the healthcare sector by promoting preventive care and reducing the need for hospital and nursing home admissions. InnovAge Holding Corp. plays a pivotal role in the healthcare market by offering an alternative to traditional elder care, emphasizing fiscal responsibility and sustainability. By coordinating care across various providers and services, InnovAge improves healthcare efficiency and accessibility for an aging population. Headquartered in Denver, Colorado, the company continues to expand its reach across the United States, driven by an increasing demand for senior care services.
CEO Mr. Patrick Blair · 2,440 employees · United States · https://www.innovage.com